rss
J Clin Pathol doi:10.1136/jcp.2008.059766

CD30-positive DLBCL with microvillous features: So-called microvillous lymphoma

  1. Aimin Liu (aimin{at}nms.ac.jp)
  1. Central Institute for Electron Microscopic Researches, Nippon Medical School, Tokyo, Japan
    1. Yuichi Sugisaki (y-sugisaki{at}nms.ac.jp)
    1. Department of Pathology, Nippon Medical School, Tokyo, Japan
      1. Masaru Hosone (m-hosone{at}nms.ac.jp)
      1. Department of Pathology, Nippon Medical School, Tokyo, Japan
        1. Shigeki Namimatsu (s-namimatsu{at}nms.ac.jp)
        1. Department of Pathology, Nippon Medical School, Tokyo, Japan
          1. Shotaro Maeda (maeda-s{at}nms.ac.jp)
          1. Department of Pathology, Nippon Medical School, Tokyo, Japan
            1. Zenya Naito (naito{at}nms.ac.jp)
            1. Department of Pathology, Nippon Medical School, Tokyo, Japan
              1. Mohammad Ghazizadeh (ciem{at}nms.ac.jp)
              1. Central Institute for Electron Microscopic Researches, Nippon Medical School, Tokyo, Japan
                • Published Online First 6 January 2009

                Abstract

                Abstract Microvillous Lymphomas (MVLs) are a rare entity, and currently considered as an unusual morphologic variant of diffuse large B-cell lymphoma (DLBCL) characterized by a cohesive sinusoidal growth pattern and ultrastructural microvillous projections. Most MVLs are negative for CD30. Only a few cases of MVLs with CD30 positivity have been reported in the literature. We present one case of CD30-positive MVLs in an 87-year-old man who was encountered generalized lymphadenopathy. Histopathologically, the tumor showed a morphologic mimic of anaplastic large cell lymphoma (ALCL) with sinusoidal growth pattern. Immunohistochemically (IHC), the tumor cells were CD30+, CD20+, CD45+, BCL-2+, BCL-6+, MUM1+, Ki-67+, CD45RO-, CD3-, CD10-, CD15-, CD56-, EMA-, TIA-1- and ALK-. Flow cytometry analysis (FCM) result was confirmed the IHC. In situ hybridization for Epstein-Barr (EB) virus RNA was negative. Electron microscopically (EM), the tumor cells were similar to large transformed lymphocytes and had circumferentially profuse microvillous projections resembling those of epithelial mesothelioma cells. In conclusion, CD30-positive MVLs are indistinguishable from ALCLs that have ultrastructual microvillous projections by morphology alone. However, the lack of EMA, TIA-1 and ALK expression in our MVL case facilitated a definite distinction from ALCLs. The results of a panel of 3 markers (CD10-, Bcl-6+ and MUM1+) suggested that the present case of CD30-positive MVLs has an activated non-germinal center (GC) B-cell origin.

                Register for free content


                Free trial
                Individuals may register for a free 60 day online trial to all content.

                Free archive
                The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

                Don't forget to sign up for content alerts so you keep up to date with all the articles as they ar